Ross, A., Donachie, P., Sallam, A., Stratton, I., Mohamed, Q., Scanlon, P., . . . Johnston, R. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

Ross, A., P. Donachie, A. Sallam, I. Stratton, Q. Mohamed, P. Scanlon, J. Kirkpatrick, and R. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.

Ross, A., et al. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.